Clinical Trials Directory

Trials / Completed

CompletedNCT01864330

Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dry eye syndrome is a highly prevalent ocular disease with an increasing incidence in the elderly population. Topically administered lubricants are the basis for treatment of this disease. However, information about the corneal residence time of topical lubricants is still sparse, therefore no ideal treatment regimen has been found. Recently a new method for assessment of tear film thickness based on optical coherence tomography (OCT) has become available. The aim of the present study is to assess corneal residence time of three different formulations of topical lubricants, in particular Thealoz Duo® Eye Drops, Hyabak® Eye Drops and Hydrabak® Eye Drops in patients with moderate dry eye disease. In addition, standard tests for dry eye syndrome, such as the ocular surface disease index (OSDI©), Schirmer I test and determination of tear break up time (BUT) will be performed..

Conditions

Interventions

TypeNameDescription
DEVICEThealoz Duo®Eye Drops
DEVICEHyabak®Eye Drops
DEVICEHydrabak®Eye Drops

Timeline

Start date
2013-05-01
Primary completion
2013-08-01
Completion
2013-09-01
First posted
2013-05-29
Last updated
2013-11-27

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01864330. Inclusion in this directory is not an endorsement.